• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4809841)   Today's Articles (3446)
For: Wong YJ, Nguyen MH. Is it safe to treat chronic hepatitis C patients with decompensated cirrhosis with protease inhibitors-based direct-acting antivirals? Liver Int 2022;42:1207-1208. [PMID: 35220647 DOI: 10.1111/liv.15214] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Number Cited by Other Article(s)
1
Quek J, Varun D, Loo JH, Yew KC, Hsiang J, Thurairajah PH, Tan CK, Kumar R, Wong YJ. Hepatitis C elimination in Singapore: Current status and future directions. J Gastroenterol Hepatol 2025;40:339-340. [PMID: 39442964 DOI: 10.1111/jgh.16773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2024] [Accepted: 09/29/2024] [Indexed: 10/25/2024]
2
Wong YJ, Kumar R, Kumar R, Tan J, Liu CH, Hui VW, Tan SS, Kao JH, Wong GL, Thurairajah PH. Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor-experienced patients with hepatitis C: Real-world data from a multicenter Asian registry. J Gastroenterol Hepatol 2022;37:1642-1644. [PMID: 35723645 PMCID: PMC9543910 DOI: 10.1111/jgh.15918] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Accepted: 06/16/2022] [Indexed: 12/12/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA